BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7149068)

  • 1. The dexamethasone suppression test in patients with borderline personality disorders.
    Soloff PH; George A; Nathan RS
    Am J Psychiatry; 1982 Dec; 139(12):1621-3. PubMed ID: 7149068
    [No Abstract]   [Full Text] [Related]  

  • 2. The dexamethasone suppression test in borderline personality disorder.
    Krishnan KR; Davidson JR; Rayasam K; Shope F
    Biol Psychiatry; 1984 Jul; 19(7):1149-53. PubMed ID: 6477995
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.
    Beeber AR; Kline MD; Pies RW; Manring JM
    J Nerv Ment Dis; 1984 May; 172(5):301-3. PubMed ID: 6716096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 5. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interface between borderline personality disorder and affective disorder.
    Gunderson JG; Elliott GR
    Am J Psychiatry; 1985 Mar; 142(3):277-88. PubMed ID: 2857532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, borderline disorder, and the DST.
    Am J Psychiatry; 1983 Jun; 140(6):818-20. PubMed ID: 6846653
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinguishing subtypes within the borderline domain: a combined psychoneuroendocrine approach.
    Steiner M; Martin S; Wallace JE; Goldman S
    Biol Psychiatry; 1984 Jun; 19(6):907-11. PubMed ID: 6743724
    [No Abstract]   [Full Text] [Related]  

  • 9. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
    Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
    J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DST in borderline patients.
    Dilsaver SC; Greden JF
    Am J Psychiatry; 1983 Nov; 140(11):1540-1. PubMed ID: 6625014
    [No Abstract]   [Full Text] [Related]  

  • 11. [New diagnostic and neuroendocrine approaches to the borderline syndrome].
    Castro P; Pardoen D; Toscano-Aguilar M; Mendlewicz J
    Encephale; 1986; 12(1):27-30. PubMed ID: 3698888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of suicidal behavior in depressed borderline inpatients.
    Friedman RC; Aronoff MS; Clarkin JF; Corn R; Hurt SW
    Am J Psychiatry; 1983 Aug; 140(8):1023-6. PubMed ID: 6869585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DST and Axis I diagnoses in borderline personality.
    Pitts FN
    J Clin Psychiatry; 1984 Apr; 45(4):149. PubMed ID: 6715285
    [No Abstract]   [Full Text] [Related]  

  • 16. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
    Lahmeyer HW; Val E; Gaviria FM; Prasad RB; Pandey GN; Rodgers P; Weiler MA; Altman EG
    Psychiatry Res; 1988 Jul; 25(1):19-30. PubMed ID: 3217463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three systems for diagnosing borderline personality disorder.
    Nelson HF; Tennen H; Tasman A; Borton M; Kubeck M; Stone M
    Am J Psychiatry; 1985 Jul; 142(7):855-8. PubMed ID: 4014508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in borderline personality disorder: lifetime prevalence at interview and longitudinal course of symptoms.
    Perry JC
    Am J Psychiatry; 1985 Jan; 142(1):15-21. PubMed ID: 3871311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is bulimia associated with borderline personality disorder? A controlled study.
    Pope HG; Frankenburg FR; Hudson JI; Jonas JM; Yurgelun-Todd D
    J Clin Psychiatry; 1987 May; 48(5):181-4. PubMed ID: 3571171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.